Ophthalmology Times - Ophthalmology news, articles, and events
WEBEfficacy of novel eye drop to reverse cataracts after phase 1/2 study. By Lynda Charters. August 25th 2024. The drop improves vision by breaking up degraded protein complexes that cause lens clouding. Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 · Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to the company, pilocarpine HCl ...
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 · The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
WEBAug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
2021 Best Program results: Wilmer Eye Institute grabs top spot
WEBNov 12, 2021 · The year 2021 saw the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, snaring the top spot in the Overall Best Program category.. The Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, Miami, and Massachusetts Eye and Ear, Harvard Medical School, Harvard University, Boston, earned the second and third spots, respectively.
News - Ophthalmology Times
WEBSep 8, 2024 · Merck and EyeBio announce initiation of phase 2b/3 BRUNELLO trial evaluating MK-3000 for treatment of diabetic macular edema. September 5th 2024. MK-3000, formally known as EYE103, is an investigational, potentially first-in-class tetravalent, tri-specific antibody that acts as an agonist of the Wnt signaling pathway.
Breaking down the dorzolamide shortage - Ophthalmology Times
WEBAug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in …
Intense pulsed light therapy for the treatment of chalazia
WEBMay 17, 2019 · Intense pulsed light therapy for the treatment of chalazia. Laura M. Periman, MD, discusses her experience using intense pulsed light (IPL) therapy and how this modality can quickly rid patients of painful chalazions at the annual 2019 ASCRS meeting in San Diego. Moderate-monovision outcomes see improvement with small aperture IOLs.
The who, what, when, why and how of selective laser trabeculoplasty
WEBDec 1, 2015 · Laser trabeculoplasty is a minimally invasive laser therapy that helps regulate aqueous outflow. Selective laser trabeculoplasty (SLT) was approved by the United States Food and Drug Administration in 2001 and is currently the most commonly performed laser trabeculoplasty procedure because of its good safety profile.
Dry eye paradise: FDA green-lights Miebo as first and only eye …
WEBJun 21, 2023 · According to the companies, perfluorohexyloctane ophthalmic solution is the first and only FDA-approved treatment for DED that directly targets tear evaporation instead of tear formation. Formerly known as NOV03, the drug was developed by Novaliq, and Bausch + Lomb attained exclusive licensing in the United States and Canada in 2019. 12.